Drug Profile
Gallanilide
Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Class I antiarrhythmics; Class III antiarrhythmics; Hydroxybenzoic acids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 03 Sep 1997 New profile
- 03 Sep 1997 Preclinical development for Arrhythmias in China (Unknown route)